Sugg U, Erhardt S, Morgenroth T, Flehmig B. Is the use of the term 'posttransfusion hepatitis type B' in its conventional sense still justifiable?
Vox Sang 1983;
44:305-11. [PMID:
6858078 DOI:
10.1111/j.1423-0410.1983.tb04487.x]
[Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
We have investigated 8 cases of clinically manifest hepatitis type B said to be posttransfusion hepatitis that have become known in the years 1978-1981. Paired samples of serum from all 54 blood donors implicated have been drawn at the time of the donation in question as well as a few months later. Only 1 donor, negative for HBsAg but positive with high titer for anti-HBc, could have been a possible source of infection. There is strong evidence that this person is a chronic low level carrier. In the case of 2 other patients transmission of hepatitis by clotting factors from pooled plasma cannot be denied. Regarding the remaining 5 cases, there is no hint whatsoever for a causal connection between blood transfusion and hepatitis type B.
Collapse